아미쿠스 테라 (FOLD)

Jul 23, 2025

What drives Amicus Therapeutics Inc. stock priceExceptional profit margins - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Amicus Therapeutics Inc. Stock Analysis and ForecastFree Technical Analysis Support - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Edgestream Partners L.P. Makes New Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 22, 2025

Jul 22, 2025

What analysts say about Amicus Therapeutics Inc. stockSkyrocketing investment returns - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Published on: 2025-07-23 00:04:03 - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025 - GlobeNewswire

Jul 22, 2025

Jul 21, 2025

Amicus Therapeutics Sets Date for Q2 Earnings: Key Updates Expected from Rare Disease Pipeline - Stock Titan

Jul 21, 2025

Jul 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Stock Rating Upgraded by Morgan Stanley - MarketBeat

Jul 20, 2025

Jul 20, 2025

Is Amicus Therapeutics Inc. a good long term investmentRemarkable growth - PrintWeekIndia

Jul 20, 2025

Jul 20, 2025

Amicus Therapeutics (NASDAQ:FOLD) Shares Gap UpWhat's Next? - MarketBeat

Jul 20, 2025

Jul 19, 2025

Amicus (FOLD) Gets Japan Approval for Pombiliti + Opfolda - MSN

Jul 19, 2025

Jul 17, 2025

Amicus gains as Morgan Stanley upgrades on Aurobindo case and Pom-Op switching - MSN

Jul 17, 2025

Jul 17, 2025

Amicus stock gains as Morgan Stanley upgrades (FOLD:NASDAQ) - Seeking Alpha

Jul 17, 2025

Jul 17, 2025

Amicus Therapeutics: A Biotech Buy with Legal, Product, and Market Catalysts - AInvest

Jul 17, 2025

Jul 17, 2025

Amicus Therapeutics (FOLD) Soars 10.05% on Japan Approval - AInvest

Jul 17, 2025

Jul 17, 2025

Rice Hall James & Associates LLC Increases Stock Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 17, 2025

Jul 17, 2025

Amicus Therapeutics stock upgraded to Overweight by Morgan Stanley on IP strength - Investing.com Canada

Jul 17, 2025

Jul 17, 2025

Stephens Investment Management Group LLC Makes New $5 Million Investment in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Jul 17, 2025

Jul 16, 2025

10 Best Small-Cap Stocks to Buy According to Billionaires - Insider Monkey

Jul 16, 2025

Jul 14, 2025

Q2 EPS Estimate for Amicus Therapeutics Increased by Analyst - MarketBeat

Jul 14, 2025

Jul 13, 2025

Zacks Research Issues Optimistic Forecast for FOLD Earnings - MarketBeat

Jul 13, 2025

Jul 13, 2025

Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) PT at $16.22 - MarketBeat

Jul 13, 2025

Jul 12, 2025

Amicus Therapeutics (FOLD): Securing Rare Disease Dominance Through Strategic Deals and Pipeline Momentum - AInvest

Jul 12, 2025

Jul 12, 2025

TD Cowen Remains Bullish on Amicus Therapeutics (FOLD) With a $20 PT - Yahoo Finance

Jul 12, 2025

Jul 10, 2025

SHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the Firm - Longview News-Journal

Jul 10, 2025